| Deborah Rogers, | |
|
305 W Pennsylvania Ave, Anaconda, MT 59711-1900 | |
| (406) 563-8500 | |
| (406) 563-8694 |
| Full Name | Deborah Rogers |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 305 W Pennsylvania Ave, Anaconda, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205034568 | NPI | - | NPPES |
| 1205034568 | Other | MT | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | MD021630E (Pennsylvania) | Primary |
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538597703 PECOS PAC ID: 8123938974 Enrollment ID: O20031119000745 |
News Archive
Researchers have created a new method for screening cells used in immunotherapy cancer treatments, allowing high-performing immune system cells to be studied in isolation and potentially expanding the number of patients for whom the breakthrough treatment proves successful.
Colonoscopy is a safe and effective medical procedure that's proven to saves lives. Used for routine cancer screening, it can help identify colon tumors in their early stages. In addition, it is a key non-surgical imaging technique that allows doctors to spot ulcers, polyps or bleeding inside the large intestines of their patients safely, avoiding complications that an exploratory surgery might induce.
President Obama's "comments on foreign aid [in Ghana] make it all the more surprising that the only real change in our foreign assistance programs under his administration so far is in indicated spending" - Carol Adelman, director of the Center for Global Prosperity at the Hudson Institute, and Nicholas Eberstadt, a political economy scholar at the American Enterprise Institute - write in a Weekly Standard opinion piece.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Rogers, 401 W Pennsylvania Ave, Anaconda, MT 59711-1999 Ph: (406) 563-8500 | Deborah Rogers, 305 W Pennsylvania Ave, Anaconda, MT 59711-1900 Ph: (406) 563-8500 |
News Archive
Researchers have created a new method for screening cells used in immunotherapy cancer treatments, allowing high-performing immune system cells to be studied in isolation and potentially expanding the number of patients for whom the breakthrough treatment proves successful.
Colonoscopy is a safe and effective medical procedure that's proven to saves lives. Used for routine cancer screening, it can help identify colon tumors in their early stages. In addition, it is a key non-surgical imaging technique that allows doctors to spot ulcers, polyps or bleeding inside the large intestines of their patients safely, avoiding complications that an exploratory surgery might induce.
President Obama's "comments on foreign aid [in Ghana] make it all the more surprising that the only real change in our foreign assistance programs under his administration so far is in indicated spending" - Carol Adelman, director of the Center for Global Prosperity at the Hudson Institute, and Nicholas Eberstadt, a political economy scholar at the American Enterprise Institute - write in a Weekly Standard opinion piece.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
› Verified 2 days ago